Aukning öndunarfæraeinkenna og notkunar astmalyfja meðal Íslendinga á aldrinum 20-44 ára

• Main Authors: Stefán Sigurkarlsson, Michael Clausen, Þórarinn Gíslason, Davíð Gíslason
• Format: Article in Journal/Newspaper
• Language: Icelandic
• Published: Læknafélag Íslands, Læknafélag Reykjavíkur 2011
• Subjects: Asma; Öndunarfærasjúkdómar; Lyfjanotkun; Adult; Age Factors; Anti-Asthmatic Agents; Asthma; Cross-Sectional Studies; Drug Utilization; Female; Humans; Iceland; Male; Physician's Practice Patterns; Prevalence; Questionnaires; Time Factors; Treatment Outcome; Young Adult
• Online Access: http://hdl.handle.net/2336/146559

In the year 1990 the European Community Respiratory Health Survey I (ECRHS I) demonstrated that the prevalence of these diseases was lowest in Iceland (www.ecrhs.org). In order to compare the prevalence of respiratory symptoms in Reykjavik over time, a new identical cross-sectional study was performed seventeen years later. Both cohorts, were in the age group 20-44 years and randomly selected from the population in Reykjavik and suburbs. Both answered questionnaires about respiratory symptoms, nasal allergy and use of anti-asthmatic drugs. The second cohort was part of the EuroPrevall study (www.europrevall.org) performed in 2007. Response rate was lower in 2007 (999 or 43.2%) than in 1990 (2.903 or 80.6%).The prevalence of attacks of asthma increased over time from 2.2% to 6.7% (p<0.0001), use of anti-asthmatic drugs increased from 2.4% to 7.2% (p<0.0001) and nasal allergy symptoms from 17.8% to 29.3% (p< 0.0001). There was an increase of all respiratory symptoms except wheezing or whistling, where the prevalence dropped from 18.0% to 14.4% (p<0.01). In the year 2007 women had more often been woken by attacks of coughing (p<0.0001), had more often attacks of asthma (p<0.05) and were more likely to use anti-asthmatic drugs (p<0.05) than men. Attacks of asthma and the use of anti-asthmatic drugs were more common among the younger age group in the year 2007. That was not seen in the year 1990. This study provides evidence of an increase in respiratory symptoms and use of anti-asthmatic drugs over a period of 17 years from 1990 among young adult Icelanders. Inngangur: Við samanburð milli 15 þjóða í Evrópurannsókninni Lungu og heilsa (ECRHS I) árið 1990 reyndist vera minnst um ofnæmissjúkdóma á Íslandi. Í þessari rannsókn eru niðurstöður tveggja þverskurðarrannsókna bornar saman til þess að meta hvort öndunarfæraeinkenni og notkun astmalyfja hafi aukist á Íslandi á 17 ára tímabili frá 1990. Efniviður og aðferðir: Rannsóknarhóparnir voru á aldrinum 20-44 ára og valdir af handahófi á ...